A_feasibility_study_of_the_SDI_test_for_the_evaluation_of_gastrointestinal_cancer_sensitivity_to_anticancer_drugs._The_succinic_dehydrogenase_inhibition_(SDI)_test_has_been_widely_used_to_evaluate_the_sensitivity_of_cancer_cells_to_anticancer_agents._Recently,_the_techniques_for_tissue_culture_have_progressed;_the_ability_to_make_formazan_has_improved_with_the_use_of_methylthiazol_tetrazolium_bromide_(MTT)_instead_of_triphenyl_tetrazolium_chloride_(TTC)_in_this_assay._Therefore,_we_modified_the_SDI_test_in_order_to_evaluate_the_drug_response_to_gastrointestinal_cancer_and_applied_it_in_a_clinical_study._In_this_assay,_the_optimal_concentration_levels_of_mytomycin-C_and_Adriamycin_for_the_clinical_materials_are_10_micrograms/ml,_that_is,_10_times_higher_than_for_the_cancer_cell_line,_and_that_of_Cisplatin_is_30_micrograms/ml,_for_Cisplatin_is_unstable_in_the_culture_medium._To_evaluate_its_antitumor_effect,_it_was_found_necessary_to_expose_the_cancer_cells_to_5-fluorouracil_(5-FU)_for_3_days._We_applied_this_assay_for_the_clinical_materials;_the_evaluable_rate_of_this_assay_is_83.3%._The_peculiarity_of_this_assay_is_its_high_evaluable_rate._These_results_suggest_that_this_test_may_be_useful_for_clinical_application.